Header Logo

Connection

Mayer Davidson to Humans

Back to Details
This is a "connection" page, showing publications Mayer Davidson has written about Humans.
Mayer Davidson
Connection Strength
5.495
Humans
  1. Glycaemic treatment of newly diagnosed type 2 diabetes. Diabetes Obes Metab. 2024 Nov; 26(11):5492-5493.
    View in: PubMed
    Score: 0.105
  2. Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians. Diabetes Obes Metab. 2024 Aug; 26(8):3475-3477.
    View in: PubMed
    Score: 0.104
  3. In adults with BMI =27 kg/m2 and type 2 diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk. Ann Intern Med. 2023 11; 176(11):JC129.
    View in: PubMed
    Score: 0.100
  4. Review of Prediabetes. JAMA. 2023 08 08; 330(6):564.
    View in: PubMed
    Score: 0.098
  5. A simplified straightforward protocol for the use of U-500 regular insulin. Diabetes Obes Metab. 2023 02; 25(2):634-636.
    View in: PubMed
    Score: 0.093
  6. In adults with obesity without diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk. Ann Intern Med. 2022 10; 175(10):JC116.
    View in: PubMed
    Score: 0.092
  7. Comment on Aleppo et al. The Effect of Discontinuing Continuous Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737. Diabetes Care. 2022 04 01; 45(4):e84.
    View in: PubMed
    Score: 0.089
  8. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care 2020;43:2916-2922. Diabetes Care. 2021 05; 44(5):e105.
    View in: PubMed
    Score: 0.084
  9. Metformin Should Not Be Used to Treat Prediabetes. Diabetes Care. 2020 09; 43(9):1983-1987.
    View in: PubMed
    Score: 0.080
  10. The "Cost-Effective" beneficial effect of pioglitazone on cardiovascular disease. Diabetes Res Clin Pract. 2020 07; 165:108223.
    View in: PubMed
    Score: 0.078
  11. Second-generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costs. Diabetes Obes Metab. 2020 05; 22(5):719-721.
    View in: PubMed
    Score: 0.077
  12. SGLT-2 inhibitors were not linked to severe or nonsevere UTIs vs DPP-4 inhibitors or GLP-1 agonists. Ann Intern Med. 2019 12 17; 171(12):JC70.
    View in: PubMed
    Score: 0.076
  13. Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot study. J Diabetes. 2020 Jan; 12(1):91-94.
    View in: PubMed
    Score: 0.075
  14. The Case for Using Human Insulin. Am J Med. 2020 02; 133(2):e23-e24.
    View in: PubMed
    Score: 0.074
  15. Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes. Ann Intern Med. 2019 04 16; 170(8):JC39.
    View in: PubMed
    Score: 0.073
  16. Delayed response to an injection of U-500 regular insulin is not rare. J Diabetes. 2019 Jul; 11(7):519-521.
    View in: PubMed
    Score: 0.072
  17. An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis. Diabetes Res Clin Pract. 2018 Jan; 135:102-110.
    View in: PubMed
    Score: 0.066
  18. Effectiveness of certified diabetes educators following pre-approved protocols to redesign diabetes care delivery in primary care: Results of the REMEDIES 4D trial. Contemp Clin Trials. 2018 01; 64:201-209.
    View in: PubMed
    Score: 0.065
  19. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections. JAMA. 2017 01 24; 317(4):363-364.
    View in: PubMed
    Score: 0.062
  20. Diabetic retinopathy is not present in non-diabetic older overweight/obese African Americans. Diabetes Res Clin Pract. 2017 04; 126:322.
    View in: PubMed
    Score: 0.062
  21. Diabetic retinopathy is not present in newly diagnosed diabetic patients. Diabetologia. 2016 12; 59(12):2727.
    View in: PubMed
    Score: 0.061
  22. A Reappraisal of Prediabetes. J Clin Endocrinol Metab. 2016 07; 101(7):2628-35.
    View in: PubMed
    Score: 0.060
  23. Pioglitazone (Actos) and bladder cancer: Legal system triumphs over the evidence. J Diabetes Complications. 2016 08; 30(6):981-5.
    View in: PubMed
    Score: 0.059
  24. Response to comment on Kahn and Davidson. The reality of type 2 diabetes prevention. Diabetes Care 2014;37:943-949. Diabetes Care. 2014 Dec; 37(12):e276-7.
    View in: PubMed
    Score: 0.054
  25. Response to comment on Grunberger "insulin analogs-are they worth it? Yes!" Diabetes Care 2014;37:1767-1770 and Davidson "insulin analogs-is there a compelling case to use them? No!" Diabetes Care 2014;37:1771-1774. Diabetes Care. 2014 Oct; 37(10):e231.
    View in: PubMed
    Score: 0.053
  26. Response to comment on Kahn and Davidson. The reality of type 2 diabetes prevention. Diabetes care 2014;37:943-949. Diabetes Care. 2014 Aug; 37(8):e187.
    View in: PubMed
    Score: 0.052
  27. Rationale, design, and implementation of a cluster randomized trial using certified diabetes educators to intensify treatment for glycemia, blood pressure and lipid control: REMEDIES 4D. Contemp Clin Trials. 2014 Sep; 39(1):124-31.
    View in: PubMed
    Score: 0.052
  28. Effect of long term vitamin D supplementation on biomarkers of inflammation in Latino and African-American subjects with pre-diabetes and hypovitaminosis D. Horm Metab Res. 2015 Apr; 47(4):280-3.
    View in: PubMed
    Score: 0.052
  29. Insulin analogs--is there a compelling case to use them? No! Diabetes Care. 2014 Jun; 37(6):1771-4.
    View in: PubMed
    Score: 0.052
  30. Epidemiological ramifications of diagnosing diabetes with HbA1c levels. J Diabetes Complications. 2014 Jul-Aug; 28(4):464-9.
    View in: PubMed
    Score: 0.051
  31. The reality of type 2 diabetes prevention. Diabetes Care. 2014 Apr; 37(4):943-9.
    View in: PubMed
    Score: 0.051
  32. Self-mixed/split insulin regimen: a serious omission in the ADA/EASD position statement. Diabetes Care. 2014; 37(1):3-4.
    View in: PubMed
    Score: 0.050
  33. Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos. Ethn Dis. 2014; 24(2):195-9.
    View in: PubMed
    Score: 0.050
  34. Response to comment on: Davidson et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013;36:260-266. Diabetes Care. 2013 May; 36(5):e72.
    View in: PubMed
    Score: 0.048
  35. Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610. Diabetes Care. 2013 Jan; 36(1):e10.
    View in: PubMed
    Score: 0.047
  36. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care. 2013 Feb; 36(2):260-6.
    View in: PubMed
    Score: 0.046
  37. Comment on: Hellemons et al. Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial. Diabetes Care 2011;34:2078-2083. Diabetes Care. 2011 Dec; 34(12):e188.
    View in: PubMed
    Score: 0.044
  38. Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus. Endocr Pract. 2011 Sep-Oct; 17(5):691-8.
    View in: PubMed
    Score: 0.043
  39. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure. Endocr Pract. 2011 May-Jun; 17(3):395-403.
    View in: PubMed
    Score: 0.042
  40. Collaborative care for depression and chronic illnesses. N Engl J Med. 2011 03 31; 364(13):1278; author reply 1278-9.
    View in: PubMed
    Score: 0.042
  41. Diagnosing diabetes with glucose criteria: worshiping a false God. Diabetes Care. 2011 Feb; 34(2):524-6.
    View in: PubMed
    Score: 0.041
  42. Evaluation of self monitoring of blood glucose in non-insulin-treated diabetic patients by randomized controlled trials: little bang for the buck. Rev Recent Clin Trials. 2010 Sep; 5(3):138-42.
    View in: PubMed
    Score: 0.040
  43. Integrating nurse-directed diabetes management into a primary care setting. Am J Manag Care. 2010 Sep; 16(9):652-6.
    View in: PubMed
    Score: 0.040
  44. Counterpoint: postprandial glucose levels are not a clinically important treatment target. Diabetes Care. 2010 Aug; 33(8):1908-10.
    View in: PubMed
    Score: 0.040
  45. Correction to the 2010 report on the diagnosis and classification of diabetes. Diabetes Care. 2010 Apr; 33(4):e57.
    View in: PubMed
    Score: 0.039
  46. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010 Mar; 87(3):415-21.
    View in: PubMed
    Score: 0.038
  47. U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010 Feb; 33(2):281-3.
    View in: PubMed
    Score: 0.038
  48. Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009 Dec; 32(12):2156-60.
    View in: PubMed
    Score: 0.037
  49. Novel noninvasive breath test method for screening individuals at risk for diabetes: response to Dillon et al. Diabetes Care. 2009 Jul; 32(7):e88; author reply e89.
    View in: PubMed
    Score: 0.037
  50. Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation. Curr Opin Endocrinol Diabetes Obes. 2009 Apr; 16(2):107-12.
    View in: PubMed
    Score: 0.036
  51. How our current medical care system fails people with diabetes: lack of timely, appropriate clinical decisions. Diabetes Care. 2009 Feb; 32(2):370-2.
    View in: PubMed
    Score: 0.036
  52. Detailed treatment algorithms for effective nurse- and pharmacist-directed diabetes care: a personal approach. Diabetes Educ. 2009 Jan-Feb; 35(1):61-71.
    View in: PubMed
    Score: 0.036
  53. No need for the needle (at first). Diabetes Care. 2008 Oct; 31(10):2070-1.
    View in: PubMed
    Score: 0.035
  54. The relationship of glycaemic control and triglycerides in patients with diabetes mellitus: a PreCIS Database Study. Diabetes Obes Metab. 2009 Feb; 11(2):118-22.
    View in: PubMed
    Score: 0.034
  55. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008 Jul; 93(7):2447-53.
    View in: PubMed
    Score: 0.034
  56. Metformin does not suppress thyrotropin. Endocr Pract. 2008 Mar; 14(2):252-3.
    View in: PubMed
    Score: 0.034
  57. The effectiveness of nurse- and pharmacist-directed care in diabetes disease management: a narrative review. Curr Diabetes Rev. 2007 Nov; 3(4):280-6.
    View in: PubMed
    Score: 0.033
  58. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract. 2007 Jul-Aug; 13(4):427-8.
    View in: PubMed
    Score: 0.032
  59. Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care. 2007 Sep; 30(9):2233-5.
    View in: PubMed
    Score: 0.032
  60. The dilemma of self-monitoring of blood glucose. Diabetologia. 2007 Mar; 50(3):497-9.
    View in: PubMed
    Score: 0.031
  61. Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population. Diabetes Care. 2007 Feb; 30(2):224-7.
    View in: PubMed
    Score: 0.031
  62. Clinical implications of the DREAM Study. Diabetes Care. 2007 Feb; 30(2):418-20.
    View in: PubMed
    Score: 0.031
  63. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.
    View in: PubMed
    Score: 0.031
  64. Does the metabolic syndrome exist: response to Grundy. Diabetes Care. 2006 Nov; 29(11):2565; author reply 2565-6.
    View in: PubMed
    Score: 0.031
  65. Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes. Diabetes Care. 2006 Jun; 29(6):1395-6.
    View in: PubMed
    Score: 0.030
  66. Effective diabetes care by a registered nurse following treatment algorithms in a minority population. Am J Manag Care. 2006 Apr; 12(4):226-32.
    View in: PubMed
    Score: 0.029
  67. Recommendations for management of diabetes during Ramadan. Diabetes Care. 2006 Mar; 29(3):745; author reply 746.
    View in: PubMed
    Score: 0.029
  68. Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with diabetes hospitalized for a cardiac event. Am J Manag Care. 2005 Dec; 11(12):758-64.
    View in: PubMed
    Score: 0.029
  69. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al. Diabetes Care. 2005 Oct; 28(10):2597; author reply 2597-8.
    View in: PubMed
    Score: 0.028
  70. The effect of disease management programs for patients with diabetes mellitus on processes and outcomes of care. Am J Manag Care. 2005 Sep; 11(9):585; author reply 585.
    View in: PubMed
    Score: 0.028
  71. Exenatide. Nat Rev Drug Discov. 2005 Sep; 4(9):713-4.
    View in: PubMed
    Score: 0.028
  72. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005 Jun; 28(6):1531-3.
    View in: PubMed
    Score: 0.028
  73. SF-36 and diabetes outcome measures. Diabetes Care. 2005 Jun; 28(6):1536-7.
    View in: PubMed
    Score: 0.028
  74. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005 Apr; 118(4):422-5.
    View in: PubMed
    Score: 0.027
  75. Starting insulin therapy in type 2 diabetic patients: does it really matter how? Diabetes Care. 2005 Feb; 28(2):494-5.
    View in: PubMed
    Score: 0.027
  76. Glycemia and risk for cardiovascular disease. Ann Intern Med. 2005 Feb 01; 142(3):227; author reply 227-8.
    View in: PubMed
    Score: 0.027
  77. Thiazolidinediones. N Engl J Med. 2005 Jan 13; 352(2):205-7; author reply 205-7.
    View in: PubMed
    Score: 0.027
  78. Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2005 Jan; 28(1):222-4.
    View in: PubMed
    Score: 0.027
  79. Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients. Diabetes Care. 2004 Sep; 27(9):2260-1.
    View in: PubMed
    Score: 0.026
  80. Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism. 2004 Sep; 53(9):1166-73.
    View in: PubMed
    Score: 0.026
  81. Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population. Diabetes Care. 2004 Jul; 27(7):1741-2.
    View in: PubMed
    Score: 0.026
  82. Triple therapy: definitions, application, and treating to target. Diabetes Care. 2004 Jul; 27(7):1834-5.
    View in: PubMed
    Score: 0.026
  83. Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et al. Diabetes Care. 2004 Jul; 27(7):1846; author reply 1847-8.
    View in: PubMed
    Score: 0.026
  84. Type-1 diabetes mellitus with insufficient serum immunoreactive insulin elevation after subcutaneous NPH-insulin injection. Diabetes Res Clin Pract. 2004 Jun; 64(3):229.
    View in: PubMed
    Score: 0.026
  85. Status of research funding by the American Diabetes Association--5th and final year. Diabetes. 2004 May; 53(5):1403.
    View in: PubMed
    Score: 0.026
  86. Status of research funding by the American Diabetes Association--5th and final year. Diabetes Care. 2004 May; 27(5):1235.
    View in: PubMed
    Score: 0.026
  87. ImmunoDip: an improved screening method for microalbuminuria. Am J Nephrol. 2004 May-Jun; 24(3):284-8.
    View in: PubMed
    Score: 0.026
  88. More evidence to support "outsourcing" of diabetes care. Diabetes Care. 2004 Apr; 27(4):995.
    View in: PubMed
    Score: 0.026
  89. Novel risk factors for atherosclerosis. JAMA. 2004 Jan 21; 291(3):301; author reply 301-2.
    View in: PubMed
    Score: 0.025
  90. Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care. 2003 Dec; 26(12):3329-30.
    View in: PubMed
    Score: 0.025
  91. Metabolic syndrome/insulin resistance syndrome/pre-diabetes: new section in diabetes care. Diabetes Care. 2003 Nov; 26(11):3179.
    View in: PubMed
    Score: 0.025
  92. Is treatment of insulin resistance beneficial independent of glycemia? Diabetes Care. 2003 Nov; 26(11):3184-6.
    View in: PubMed
    Score: 0.025
  93. The impact of using a low-literacy patient education tool on process measures of diabetes care in a minority population. J Natl Med Assoc. 2003 Nov; 95(11):1074-81.
    View in: PubMed
    Score: 0.025
  94. Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003 Aug; 26(8):2281-7.
    View in: PubMed
    Score: 0.024
  95. Status of research funded by the American Diabetes Association--year 4. Diabetes. 2003 Jun; 52(6):1588.
    View in: PubMed
    Score: 0.024
  96. Status of research funded by the American Diabetes Association--year 4. Diabetes Care. 2003 Jun; 26(6):1940.
    View in: PubMed
    Score: 0.024
  97. The case for "outsourcing" diabetes care. Diabetes Care. 2003 May; 26(5):1608-12.
    View in: PubMed
    Score: 0.024
  98. Tests of glycemia. Ann Intern Med. 2003 Mar 18; 138(6):517; author reply 517.
    View in: PubMed
    Score: 0.024
  99. Editor's comment: "It ain't necessarily so". Diabetes Care. 2002 Nov; 25(11):2116.
    View in: PubMed
    Score: 0.023
  100. Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study. J Diabetes Complications. 2002 Nov-Dec; 16(6):377-81.
    View in: PubMed
    Score: 0.023
  101. Counterpoint: the oral glucose tolerance test is superfluous. Diabetes Care. 2002 Oct; 25(10):1883-5.
    View in: PubMed
    Score: 0.023
  102. Treatment decisions for type 2 diabetes. JAMA. 2002 Apr 03; 287(13):1646-7; author reply 1647-8.
    View in: PubMed
    Score: 0.022
  103. Status of research funded by the American Diabetes Association: year 3. Diabetes Care. 2002 Mar; 25(3):626.
    View in: PubMed
    Score: 0.022
  104. Have we got the new diagnostic criteria for diabetes and impaired glucose states right? No. Curr Diab Rep. 2002 Feb; 2(1):3-4.
    View in: PubMed
    Score: 0.022
  105. Staying the course--with a few adjustments. Diabetes Care. 2002 Jan; 25(1):1.
    View in: PubMed
    Score: 0.022
  106. Established therapies for diabetes mellitus. Curr Med Res Opin. 2002; 18 Suppl 1:s13-21.
    View in: PubMed
    Score: 0.022
  107. HbA(1c) measurements do not improve the detection of type 2 diabetes in a randomly selected population. Diabetes Care. 2001 Nov; 24(11):2017-8.
    View in: PubMed
    Score: 0.022
  108. Status of research funded by the American Diabetes Association: year 2. Diabetes. 2001 May; 50(5):1222.
    View in: PubMed
    Score: 0.021
  109. Status of research funded by the American Diabetes Association: year 2. Diabetes Care. 2001 May; 24(5):952.
    View in: PubMed
    Score: 0.021
  110. Catch-22. Diabetes Care. 2001 Feb; 24(2):414-5.
    View in: PubMed
    Score: 0.021
  111. Status of research funded by the American Diabetes Association. Diabetes. 2000 Aug; 49(8):1394.
    View in: PubMed
    Score: 0.020
  112. Status of American Diabetes Association-funded research. Diabetes Care. 2000 Aug; 23(8):1206.
    View in: PubMed
    Score: 0.020
  113. Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes. J Gen Intern Med. 2000 Aug; 15(8):551-5.
    View in: PubMed
    Score: 0.020
  114. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual. 2000 Jul-Aug; 15(4):137-42.
    View in: PubMed
    Score: 0.020
  115. Effect of data management on a central server on HbA1c levels in insulin-requiring patients. Diabetes Care. 2000 May; 23(5):706-7.
    View in: PubMed
    Score: 0.020
  116. Glycosylated hemoglobin as a diagnostic test for type 2 diabetes mellitus. JAMA. 2000 Feb 02; 283(5):606-7.
    View in: PubMed
    Score: 0.019
  117. Diabetes and disenrollment in a health maintenance organization setting: a 4-year longitudinal study with a matched cohort. Diabetes Care. 1999 Sep; 22(9):1487-9.
    View in: PubMed
    Score: 0.019
  118. Diabetes case management. Ann Intern Med. 1999 May 18; 130(10):862; author reply 863.
    View in: PubMed
    Score: 0.018
  119. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA. 1999 Apr 07; 281(13):1203-10.
    View in: PubMed
    Score: 0.018
  120. Relationship between dipstick positive proteinuria and albumin:creatinine ratios. J Diabetes Complications. 1999 Jan-Feb; 13(1):52-5.
    View in: PubMed
    Score: 0.018
  121. Diabetes research and diabetes care. Where do we stand? Diabetes Care. 1998 Dec; 21(12):2152-60.
    View in: PubMed
    Score: 0.018
  122. Comments on the position statements "Management of dyslipidemia in adults with diabetes" and "diabetic retinopathy". Diabetes Care. 1998 Aug; 21(8):1378-9.
    View in: PubMed
    Score: 0.017
  123. Application of a diabetes managed care program. The feasibility of using nurses and a computer system to provide effective care. Diabetes Care. 1998 Jul; 21(7):1037-43.
    View in: PubMed
    Score: 0.017
  124. Diabetes management: improving care in HMO and community settings. Med Interface. 1997 Aug; 10(8):86-90.
    View in: PubMed
    Score: 0.016
  125. Treatment of non-insulin-dependent diabetes mellitus. Mayo Clin Proc. 1997 Jan; 72(1):92.
    View in: PubMed
    Score: 0.015
  126. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med. 1997 Jan; 102(1):99-110.
    View in: PubMed
    Score: 0.015
  127. Addition of hydrolyzed guar to enteral feeding products in type I diabetic patients. Diabetes Care. 1996 Aug; 19(8):899-900.
    View in: PubMed
    Score: 0.015
  128. Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend. J Clin Endocrinol Metab. 1996 Jul; 81(7):2423-7.
    View in: PubMed
    Score: 0.015
  129. Quality of outpatient care provided to diabetic patients. A health maintenance organization experience. Diabetes Care. 1996 Jun; 19(6):601-6.
    View in: PubMed
    Score: 0.015
  130. Clinical implications of insulin resistance syndromes. Am J Med. 1995 Oct; 99(4):420-6.
    View in: PubMed
    Score: 0.014
  131. Response to Nathan. Diabetes Care. 1995 Sep; 18(9):1306-8.
    View in: PubMed
    Score: 0.014
  132. An alternative approach to the diagnosis of diabetes with a review of the literature. Diabetes Care. 1995 Jul; 18(7):1065-71.
    View in: PubMed
    Score: 0.014
  133. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Oct; 99(10):3551-60.
    View in: PubMed
    Score: 0.013
  134. The influence of diabetes mellitus on the risk of abdominal aortic surgery. Am Surg. 1994 Jun; 60(6):436-40.
    View in: PubMed
    Score: 0.013
  135. Caveat to recommendations in the consensus statement. Treatment of hypertension in diabetes. Diabetes Care. 1994 Apr; 17(4):345-6.
    View in: PubMed
    Score: 0.013
  136. Treatment of poorly controlled type 2 diabetes. Compr Ther. 1994; 20(6):321-5.
    View in: PubMed
    Score: 0.013
  137. Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. Am J Clin Nutr. 1993 Oct; 58(4):555-60.
    View in: PubMed
    Score: 0.012
  138. Role of glucose transport and GLUT4 transporter protein in type 2 diabetes mellitus. J Clin Endocrinol Metab. 1993 Jul; 77(1):25-6.
    View in: PubMed
    Score: 0.012
  139. The challenge of blood glucose management in diabetic patients receiving enteral or parenteral nutrition. JPEN J Parenter Enteral Nutr. 1993 Jan-Feb; 17(1):1-2.
    View in: PubMed
    Score: 0.012
  140. Successful treatment of markedly symptomatic patients with type II diabetes mellitus using high doses of sulfonylurea agents. West J Med. 1992 Aug; 157(2):199-200.
    View in: PubMed
    Score: 0.011
  141. Rational use of sulfonylureas. Postgrad Med. 1992 Aug; 92(2):69-70, 73-6, 79-85.
    View in: PubMed
    Score: 0.011
  142. [Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes]. Nihon Rinsho. 2012 May; 70 Suppl 3:591-601.
    View in: PubMed
    Score: 0.011
  143. Reduction of hyperinsulinemia by glyburide--scientific fact or advertising fiction? Diabetes Care. 1992 May; 15(5):719-20.
    View in: PubMed
    Score: 0.011
  144. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012 Feb 27; 344:e486.
    View in: PubMed
    Score: 0.011
  145. Integrating an Automated Diabetes Management System into the family management of children with type 1 diabetes: results from a 12-month randomized controlled technology trial. Diabetes Care. 2012 Mar; 35(3):498-502.
    View in: PubMed
    Score: 0.011
  146. Effects of various enteral feeding products on postprandial blood glucose response in patients with type I diabetes. JPEN J Parenter Enteral Nutr. 1992 Jan-Feb; 16(1):69-74.
    View in: PubMed
    Score: 0.011
  147. Successful treatment of unusual case of brittle diabetes with sulfated beef insulin. Diabetes Care. 1991 Nov; 14(11):1109-10.
    View in: PubMed
    Score: 0.011
  148. Insulin plus a sulfonylurea agent for treating type 2 diabetes. Ann Intern Med. 1991 Jul 01; 115(1):45-53.
    View in: PubMed
    Score: 0.011
  149. Use of sulfonylurea agents in older diabetic patients. Clin Geriatr Med. 1990 Nov; 6(4):903-21.
    View in: PubMed
    Score: 0.010
  150. Modern management of the insulin-requiring patient. Compr Ther. 1990 Jul; 16(7):49-55.
    View in: PubMed
    Score: 0.010
  151. Inhibition of sleep-induced growth hormone secretion: no effect on diabetic control. Diabetes Care. 1990 Jul; 13(7):813-4.
    View in: PubMed
    Score: 0.010
  152. Individual patient data meta-analysis of trials of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: protocol for a systematic review. Prim Care Diabetes. 2009 May; 3(2):117-21.
    View in: PubMed
    Score: 0.009
  153. Screening for diabetes mellitus. Ann Intern Med. 1989 Jan 15; 110(2):168.
    View in: PubMed
    Score: 0.009
  154. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009 Jan; 32(1):193-203.
    View in: PubMed
    Score: 0.009
  155. Use oral hypoglycemics with caution...but keep caution in context. Geriatrics. 1988 Aug; 43(8):83-4.
    View in: PubMed
    Score: 0.009
  156. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia. 2008 Jan; 51(1):8-11.
    View in: PubMed
    Score: 0.008
  157. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008 Jan; 31(1):173-5.
    View in: PubMed
    Score: 0.008
  158. Effect of storage on action of NPH and regular insulin mixtures. Diabetes Care. 1987 Nov-Dec; 10(6):799-800.
    View in: PubMed
    Score: 0.008
  159. Update on therapy of diabetes mellitus: diet, sulfonylurea agents, and insulin. Mt Sinai J Med. 1987 Mar; 54(3):199-210.
    View in: PubMed
    Score: 0.008
  160. Inverse relationship of metabolic clearance rate of insulin to body mass index. Metabolism. 1987 Mar; 36(3):219-22.
    View in: PubMed
    Score: 0.008
  161. The role of glucosylated serum albumin in monitoring glycemic control in stable insulin-requiring diabetic out-patients. J Clin Endocrinol Metab. 1987 Feb; 64(2):269-73.
    View in: PubMed
    Score: 0.008
  162. Idiopathic fasting hypoglycemia in an adult. Am J Med. 1987 Feb; 82(2):303-6.
    View in: PubMed
    Score: 0.008
  163. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006 Aug; 49(8):1711-21.
    View in: PubMed
    Score: 0.008
  164. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006 Aug; 29(8):1963-72.
    View in: PubMed
    Score: 0.008
  165. Pathogenesis of type 2 diabetes mellitus: an interpretation of current data. Am J Med Sci. 1986 Jul; 292(1):35-9.
    View in: PubMed
    Score: 0.007
  166. Futility of self-monitoring of blood glucose without algorithms for adjusting insulin doses. Diabetes Care. 1986 Mar-Apr; 9(2):209-10.
    View in: PubMed
    Score: 0.007
  167. Hyperthyroid Graves' disease causes insulin antagonism. J Clin Endocrinol Metab. 1985 May; 60(5):1038-41.
    View in: PubMed
    Score: 0.007
  168. Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status. West J Med. 1985 Feb; 142(2):219-29.
    View in: PubMed
    Score: 0.007
  169. Using focus groups of older African Americans and Latinos with diabetes to modify a self-care empowerment intervention. Ethn Dis. 2005; 15(2):283-91.
    View in: PubMed
    Score: 0.007
  170. For the patient. Managing diabetes with cultural sensitivity and self-empowerment. Ethn Dis. 2005; 15(2):351.
    View in: PubMed
    Score: 0.007
  171. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care. 1983 Jul-Aug; 6(4):319-27.
    View in: PubMed
    Score: 0.006
  172. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003 Jun; 26(6):1796-801.
    View in: PubMed
    Score: 0.006
  173. Diabetes in the elderly: diagnosis and treatment. Hosp Pract (Hosp Ed). 1982 Apr; 17(4):113-20, 125, 128-9.
    View in: PubMed
    Score: 0.006
  174. The establishment of a reimbursable diabetes education program. Diabetes Educ. 1982; 8(3):31-3, 38.
    View in: PubMed
    Score: 0.005
  175. The case for routinely testing the first-voided urine specimen. Diabetes Care. 1981 May-Jun; 4(3):443-4.
    View in: PubMed
    Score: 0.005
  176. Controlling blood glucose levels in patients with type 2 diabetes mellitus. An evidence-based policy statement by the American Academy of Family Physicians and American Diabetes Association. J Fam Pract. 2000 May; 49(5):453-60.
    View in: PubMed
    Score: 0.005
  177. Role of ketogenesis in urinary sodium excretion: elucidation by nicotinic acid administration during fasting. J Clin Endocrinol Metab. 1979 Dec; 49(6):818-23.
    View in: PubMed
    Score: 0.005
  178. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism. 1979 Jun; 28(6):688-705.
    View in: PubMed
    Score: 0.005
  179. Effect of carbohydrate and noncarbohydrate sources of calories on plasma 3,5,3'-triiodothyronine concentrations in man. J Clin Endocrinol Metab. 1979 Apr; 48(4):577-81.
    View in: PubMed
    Score: 0.005
  180. The case for control in diabetes mellitus. West J Med. 1978 Sep; 129(3):193-200.
    View in: PubMed
    Score: 0.004
  181. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA. 1996 Oct 16; 276(15):1246-52.
    View in: PubMed
    Score: 0.004
  182. Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia. Metabolism. 1976 Apr; 25(4):455-64.
    View in: PubMed
    Score: 0.004
  183. Insulin sensitivity of the large human adipocyte in vitro. Diabetes. 1975 Dec; 24(12):1086-93.
    View in: PubMed
    Score: 0.004
  184. Peer review by criteria mapping: criteria for diabetes mellitus. The use of decision-making in chart audit. Ann Intern Med. 1975 Dec; 83(6):761-70.
    View in: PubMed
    Score: 0.004
  185. Metabolic studies in familial partial lipodystrophy of the lower trunk and extremities. Diabetologia. 1975 Dec; 11(6):561-8.
    View in: PubMed
    Score: 0.004
  186. Management of patients with diabetes by nurses with support of subspecialists. HMO Pract. 1995 Mar; 9(1):8-13.
    View in: PubMed
    Score: 0.003
  187. Growth hormone responses to fructose in diabetes mellitus. Acta Endocrinol (Copenh). 1974 Mar; 75(3):497-502.
    View in: PubMed
    Score: 0.003
  188. Cost-effective screening for diabetic retinopathy using a nonmydriatic retinal camera in a prepaid health-care setting. Diabetes Care. 1993 Aug; 16(8):1193-5.
    View in: PubMed
    Score: 0.003
  189. Role of growth hormone in the alteration of carbohydrate metabolism induced by oral contraceptive agents. J Clin Endocrinol Metab. 1973 Feb; 36(2):246-55.
    View in: PubMed
    Score: 0.003
  190. Effect of obesity on insulin sensitivity on human adipose tissue. Diabetes. 1972 Jan; 21(1):6-12.
    View in: PubMed
    Score: 0.003
  191. Metabolic and thermal responses to Piromen in man. J Clin Endocrinol Metab. 1971 Feb; 32(2):179-87.
    View in: PubMed
    Score: 0.003
  192. Role of synalbumin insulin antagonist in pathogenesis of diabetes mellitus. Metabolism. 1970 Sep; 19(9):668-86.
    View in: PubMed
    Score: 0.002
  193. Effect of isocaloric substitution of chocolate cake for potato in type I diabetic patients. Diabetes Care. 1990 Aug; 13(8):888-92.
    View in: PubMed
    Score: 0.002
  194. Lack of glucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes. Am J Med. 1989 Aug; 87(2):178-82.
    View in: PubMed
    Score: 0.002
  195. The variability in the action of unmodified insulin is more dependent on changes in tissue insulin sensitivity than on insulin absorption. Diabet Med. 1988 Oct; 5(7):662-6.
    View in: PubMed
    Score: 0.002
  196. Peripheral and hepatic insulin antagonism in hyperthyroidism. J Clin Endocrinol Metab. 1988 Mar; 66(3):565-9.
    View in: PubMed
    Score: 0.002
  197. Exogenous insulin therapy slows weight loss in type 2 diabetic patients. Int J Obes. 1988; 12(2):149-55.
    View in: PubMed
    Score: 0.002
  198. Effects of reserpine on biological clocks for metabolic fuels during starvation in man. Diabetes. 1968; 17:312.
    View in: PubMed
    Score: 0.002
  199. Insulin antagonism is not a primary abnormality of amyotrophic lateral sclerois but is related to disease severity. J Clin Endocrinol Metab. 1986 Jul; 63(1):41-6.
    View in: PubMed
    Score: 0.002
  200. Simple solution to problem of biostator-induced insulin aggregation. Diabetes Care. 1986 Jul-Aug; 9(4):356-8.
    View in: PubMed
    Score: 0.002
  201. Diabetes mellitus. Ann Intern Med. 1982 May; 96(5):635-49.
    View in: PubMed
    Score: 0.001
  202. Perioperative management of diabetes mellitus. Anesthesiology. 1981 Aug; 55(2):104-9.
    View in: PubMed
    Score: 0.001
  203. Obesity: a serious symptom. Ann Intern Med. 1972 Nov; 77(5):779-95.
    View in: PubMed
    Score: 0.001
  204. Studies of substrate regulation in fasting. I. Evidence for central regulation of lipolysis by plasma glucose mediated by the sympathetic nervous system. Diabetes. 1967 Aug; 16(8):576-89.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.